Elevance Health Inc. (ELV)

Elevance Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	171,959	171,340	156,595	138,639	121,867	104,213
Revenue Growth (YoY)	3.77%	9.42%	12.95%	13.76%	16.94%	13.15%
Cost of Revenue	141,188	141,623	129,677	113,466	96,998	83,778
Gross Profit	30,771	29,717	26,918	25,173	24,869	20,435
Selling, General & Admin	20,421	20,087	17,700	15,918	17,450	13,364
Other Operating Expenses	707	885	767	441	361	338
Operating Expenses	21,128	20,972	18,467	16,359	17,811	13,702
Operating Income	9,643	8,745	8,451	8,814	7,058	6,733
Interest Expense / Income	1,063	1,030	851	798	784	746
Other Expense / Income	-10	4	-6	12	36	2
Pretax Income	8,590	7,711	7,606	8,004	6,238	5,985
Income Tax	1,899	1,724	1,712	1,846	1,666	1,178
Net Income	6,691	5,987	5,894	6,158	4,572	4,807
Net Income Growth	6.04%	1.58%	-4.29%	34.69%	-4.89%	28.19%
Shares Outstanding (Basic)	232	235	239	243	249	254
Shares Change	-1.96%	-1.62%	-1.60%	-2.41%	-1.92%	-1.96%
EPS (Basic)	28.72	25.38	24.56	25.26	18.23	18.81
EPS (Diluted)	28.55	25.22	24.28	24.95	17.98	18.47
EPS Growth	8.47%	3.87%	-2.69%	38.77%	-2.65%	30.16%
Free Cash Flow	820	6,765	7,247	7,277	9,667	4,984
Free Cash Flow Per Share	3.53	28.79	30.34	29.98	38.87	19.66
Dividend Per Share	6.220	5.920	5.120	4.520	3.800	3.200
Dividend Growth	12.68%	15.63%	13.27%	18.95%	18.75%	6.67%
Gross Margin	17.89%	17.34%	17.19%	18.16%	20.41%	19.61%
Operating Margin	5.61%	5.10%	5.40%	6.36%	5.79%	6.46%
Profit Margin	3.89%	3.49%	3.76%	4.44%	3.75%	4.61%
Free Cash Flow Margin	0.48%	3.95%	4.63%	5.25%	7.93%	4.78%
Effective Tax Rate	22.11%	22.36%	22.51%	23.06%	26.71%	19.68%
EBITDA	11,169	10,486	10,132	10,104	8,176	7,864
EBITDA Margin	6.50%	6.12%	6.47%	7.29%	6.71%	7.55%
Depreciation & Amortization	1,516	1,745	1,675	1,302	1,154	1,133
EBIT	9,653	8,741	8,457	8,802	7,022	6,731
EBIT Margin	5.61%	5.10%	5.40%	6.35%	5.76%	6.46%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).